Sonoma Pharmaceuticals
SNOA
#9966
Rank
A$5.3 M
Marketcap
$3.96
Share price
-1.91%
Change (1 day)
-24.15%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -A$7.04 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$12.69 Million. In 2023 the company made an earning of -A$6.87 Million, an increase over its 2022 earnings that were of -A$10.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$7.04 Million2.42%
2023 -A$6.87 Million-31.5%
2022 -A$10.03 Million16.86%
2021 -A$8.58 Million194.32%
2020 -A$2.92 Million-58.76%
2019 -A$7.07 Million-65.66%
2018 -A$20.59 Million4.84%
2017 -A$19.64 Million-2.17%
2016 -A$20.07 Million32.12%
2015 -A$15.19 Million-307.74%
2014 A$7.31 M-197.5%
2013 -A$7.5 Million
2010 -A$11.72 Million-14.02%
2009 -A$13.63 Million-57.28%
2008 -A$31.9 Million-8.03%
2007 -A$34.69 Million3.85%
2006 -A$33.4 Million39.31%
2005 -A$23.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.09 Million 291.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion 5,179.22%๐Ÿ‡บ๐Ÿ‡ธ USA